| PMBJX | RYBHX | PMBJX / RYBHX | |
| Total Expense Ratio | 0.78 | 1.52 | 51% |
| Annual Report Gross Expense Ratio | 0.78 | 1.57 | 50% |
| Fund Existence | 25 years | 22 years | - |
| Gain YTD | -0.564 | 3.424 | -16% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 2500 | 40% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 30.9B | 71.8M | 43,036% |
| Annual Yield % from dividends | 0.06 | 0.00 | - |
| Returns for 1 year | -6.53 | -12.59 | 52% |
| Returns for 3 years | 32.39 | 3.24 | 1,001% |
| Returns for 5 years | 24.63 | -9.76 | -252% |
| Returns for 10 years | 89.12 | 3.03 | 2,944% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GDMN | 80.11 | 1.33 | +1.69% |
| WisdomTree Efcnt Gld Pls Gld Ms Stgy ETF | |||
| IBB | 166.47 | 1.21 | +0.73% |
| iShares Biotechnology ETF | |||
| ILTB | 50.22 | 0.03 | +0.06% |
| iShares Core 10+ Year USD Bond ETF | |||
| SIXP | 30.76 | -0.12 | -0.39% |
| AllianzIM US Lrg Cp 6M Bfr10 Mar/Sep ETF | |||
| EFAA | 52.28 | -0.71 | -1.34% |
| Invesco MSCI EAFE Income Advantage ETF | |||